The challenge for companies today is to ensure their diversity and inclusion (D&I) efforts have real meaning, force and strategic weight. They must also show that D&I is not simply window-dressing or a defensive response to the cultural convulsions of recent years. That means embedding D&I sustainably in corporate values as not only the right but the rational and commercially astute thing to do.
D&I in leadership is where the rubber really hits the road. If pharmaceutical companies are serious about D&I, it needs...
